rs1554488651
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP3
The NM_001308093.3(GATA4):c.525_530dupAGCCGC(p.Ala176_Ala177dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001308093.3 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.44e-7 AC: 1AN: 1343260Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 662676
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Atrioventricular septal defect 4 Uncertain:1
This sequence change duplicates 6 nucleotides in exon 2 of the GATA4 mRNA (c.525_530dupAGCCGC). This leads to the insertion of 2 amino acid residue(s) in the GATA4 protein (p.Ala178_Ala179dup) but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a GATA4-related disease. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the duplicated amino acids is currently unknown. In summary, this variant is a rare duplication sequence change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at